HEALTHCARE SERVICES GROUP INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HEALTHCARE SERVICES GROUP INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2018	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,563	1,866	2,009	1,841	1,760	1,642	1,690	1,671	1,716	1,837
Cost of revenue	1,339	1,611	1,768	1,613	1,492	1,411	1,497	1,457	1,488	1,598
Gross profit	223	256	241	228	268	231	193	215	228	239
Selling, general and administrative	105	127	137	150	151	173	140	167	183	191
Interest expense		1.36	3.09	3.46
Pre-tax income	120	133	99.9	85.1	129	65.5	44.6	53.1	52.9	67.9
Income tax	43	44.7	16.4	20.5	30.5	17	10.3	14.7	13.5	8.81
Net income	77.4	88.2	83.5	64.6	98.7	48.5	34.2	38.4	39.5	59.1
EPS, basic	1.13	1.28	1.20	0.93	1.41	0.65	0.46	0.52	0.54	0.82
EPS, diluted	1.12	1.27	1.19	0.93	1.41	0.65	0.46	0.52	0.53	0.81
Shares, basic (weighted)	68.3	68.8	69.4	69.8	70.1	74.8	74.3	74.3	73.8	72.4
Shares, diluted (weighted)	69	69.8	70	70	70.2	75	74.4	74.3	74	73
Dividend per share	0.79	0.81	0.83	0.85	0.87	0.84	0.86

Balance sheet

	FY2016	FY2017	FY2018	FY2018	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	23.9	9.56	26	27.3	139	70.8	26.3	54.3	56.8	125
Short-term investments	67.7	73.2	76.4	90.7	125	114	95.2	93.1	50.5	42.8
Receivables	271	379	342	341	255	293	309	345	331	281
Inventory										16.8
Other current assets	14	23.5	22.5	20.2	20.6	33	22.6	22.2	8.39	10.4
Total current assets	415	527	508	516	572	546	509	572	557	576
Property, plant and equipment	13.5	13.5	12.9	28.8
Lease right-of-use assets				21.2	26.1	33.2
Goodwill	44.4	51.1	51.1	51.1	51.1	74.8	75.5	75.5	75.5	79.8
Intangible assets	14.4	30.9	26.5	22.4	18.2	20.8	15.9	12.1	9.44	6.96
Other non-current assets	0.05	1.26	1.26	0		0	0.81	1.66	4.09	3.9
Total assets	528	676	693	723	785	780	721	791	803	794
Accounts payable	42.9	74.5	61.5	54.4	52.2	64.4	68.3	83.2	81.1	77.4
Accrued liabilities	22.3	32.1	35.2	36.4	70.6	68.7	53.1	56.1	51.6	31.4
Deferred revenue									4.47	8.93
Total current liabilities	101	184	163	149	162	191	189	217	193	170
Lease liabilities			0	11.6	11.4	11.3	8.1	11.2	8.03	9.66
Other non-current liabilities					0	10.5	6.14	2.99	0.39	1.59
Total liabilities	190	276	252	262	315	332	303	334	303	284
Paid-in capital	218	244	259	271	282	294	302	310	318	328
Retained earnings	131	164	190	195	201	184	147	185	225	284
Treasury stock	-10.2	-9.86	-9.66	-9.44	-8.96	-30.2	-27.9	-37.7	-41.4	-102
Other comprehensive income	-0.32	0.84	0.16	2.92	5.56	4	-3.48	-1.84	-2.32	-0.45
Shareholders' equity	339	400	441	460	470	445	418	457	500	510
Total equity	339	400	441	460	470	445	418	457	500	510
Total liabilities and equity	528	676	693	723	785	778	721	791	803	794
Shares outstanding	68.1	68.9	69.3	69.6	69.9	73.8	74.1	73.3	73.2	69.6

Cash flow statement

	FY2016	FY2017	FY2018	FY2018	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	77.4	88.2	83.5	64.6	98.7	48.5	34.2	38.4	39.5	59.1
Depreciation and amortization	7.5	8.89	9.27	13.9	14.3	14.7	15.3	14.3	14.6	16.8
Stock-based compensation	4.25	5.99	5.9	6.87	7.87	8.83	9.21	8.99	9.17	12
Deferred income tax	3	1.89	-13	-0.68	-5.89	4.08	4.91	-4.82	-2.94	19.1
Change in inventory	-1.49	-1.87	0.95	4.77	4.93	5.6	4.85	2.69	1.73	-0.05
Cash from operations	41.4	7.63	80	93.6	217	37.1	-8.17	43.5	30.8	145
Capital expenditures	-5.44	-5.4	-4.94	-4.37	-4.34	-5.69	-5.21	-5.41	-6.34	-5.82
Acquisitions	0	-4.58	0	0	0	-23.9	-0.11	0	0	-7.15
Purchases of investments	-29.4	-33.9	-14.3	-33.5	-39	-20.3	-2.88	0	-52.1	-18.7
Sales and maturities of investments	28.1	28.5	9.01	21.3	6.27	26.7	10.4	1.99	67	23.2
Cash from investing	-6.45	-15	-9.59	-16.5	-36.8	-23	2.58	-3.29	6.05	-11
Stock issued	0.11	0.1	0.09	0.09	0.09	0.09	0.11	0	0
Share buybacks				0	0	-21.5	0	-11.3	-5.02	-61.6
Dividends paid	-53.3	-55.2	-57.2	-59	-60.7	-62.2	-63.4	0	0
Cash from financing	-44.3	-6.96	-54	-75.8	-68.4	-82.7	-38.9	-12.2	-31	-63.3
Net change in cash	-9.34	-14.3	16.5	1.3	112	-68.5	-44.5	28.1	5.8	70.6
Free cash flow	36	2.23	75.1	89.2	213	31.4	-13.4	38.1	24.5	139
Interest paid	0.57	1.36	3.09	3.46	1.37	1.39	2.82	7.81	6.49	1.68
Income taxes paid	32.5	35.4	37.7	20	44.9	21.2	3.31	5.59	15.2	20.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $21.05 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	17.1%	Gross profit / revenue.
Pre-tax margin	8.1%	Pre-tax income / revenue.
Net margin	6.6%	Net income / revenue.
FCF margin	8.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.3%	Cash from operations / revenue.
Effective tax rate	18.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	23.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	15.0%	Net income / average total assets.
SG&A / revenue	10.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.3%	Capital expenditures / revenue.
D&A / revenue	0.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	7.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	2.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	0.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	5.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	7.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-2.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	49.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	19.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-9.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	52.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	20.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-10.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	370.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-7.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	468.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-8.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	2.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	6.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	1.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.02x	Current assets / current liabilities.
Quick ratio	2.43x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.88x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	36.8%	Total liabilities / total assets.
Working capital	$380.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	12.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$419.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.27x	Revenue / average total assets.
Inventory turnover	97.6x	Cost of revenue / average inventory.
Days inventory	4 days	365 x average inventory / cost of revenue.
Receivables turnover	6.37x	Revenue / average receivables.
Days sales outstanding	57 days	365 x average receivables / revenue.
Days payables	20 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	41 days	Days inventory + days sales outstanding - days payables.
FCF conversion	120.8%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	3.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.76	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$26.67	Revenue / diluted weighted shares.
FCF per share	$2.12	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.21	Cash from operations / diluted weighted shares.
Book value per share	$7.63	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.18	Tangible book value / shares outstanding.
Cash per share	$2.42	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	61.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.44B	Share price x shares outstanding.
Enterprise value	$1.28B	Market cap + total debt - cash - short-term investments.
P/E	11.8x	Market cap / net income. Only when net income is positive.
P/S	0.77x	Market cap / revenue.
P/B	2.78x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.44x	Market cap / tangible book value, when positive.
P/FCF	9.73x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	9.36x	Market cap / cash from operations, when positive.
EV/Sales	0.69x	Enterprise value / revenue.
EV/FCF	8.62x	Enterprise value / free cash flow, when both are positive.
FCF yield	10.3%	Free cash flow / market cap.
Earnings yield	8.5%	Net income / market cap (the inverse of P/E).
Shareholder yield	6.4%	(Dividends paid + share buybacks) / market cap.
PEG	0.57x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was HEALTHCARE SERVICES GROUP INC's revenue in fiscal 2025?

HEALTHCARE SERVICES GROUP INC reported revenue of $1.84B for fiscal 2025, 7.1% higher than the year before.

Was HEALTHCARE SERVICES GROUP INC profitable in fiscal 2025?

Yes. Net income was $59.1M, a net margin of 3.2%.

How much free cash flow did HEALTHCARE SERVICES GROUP INC generate in fiscal 2025?

Cash from operations of $145.0M minus capital expenditures of $5.8M left free cash flow of $139.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HEALTHCARE SERVICES GROUP INC